Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Gains from Investment Securities (2017 - 2025)

KalVista Pharmaceuticals' Gains from Investment Securities history spans 9 years, with the latest figure at $369000.0 for Q2 2025.

  • On a quarterly basis, Gains from Investment Securities rose 138.12% to $369000.0 in Q2 2025 year-over-year; TTM through Apr 2025 was -$332000.0, a 304.94% decrease, with the full-year FY2025 number at $1.6 million, up 863.58% from a year prior.
  • Gains from Investment Securities hit $369000.0 in Q2 2025 for KalVista Pharmaceuticals, up from -$50000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for KALV hit a ceiling of $595000.0 in Q4 2023 and a floor of -$968000.0 in Q2 2024.
  • Historically, Gains from Investment Securities has averaged $114000.0 across 3 years, with a median of $314000.0 in 2023.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 108.4% in 2024 and later soared 138.12% in 2025.
  • Tracing KALV's Gains from Investment Securities over 3 years: stood at $595000.0 in 2023, then plummeted by 108.4% to -$50000.0 in 2024, then surged by 838.0% to $369000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for KALV at $369000.0 in Q2 2025, -$50000.0 in Q4 2024, and $317000.0 in Q3 2024.